Georgia's Online Cancer Information Center

Find A Clinical Trial

A Phase III Study of Pembrolizumab (MK-3475) vs. Chemotherapy in Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Carcinoma (KEYNOTE-177)

Status
Active
Cancer Type
Colon/Rectal Cancer
Trial Phase
Phase III
Eligibility
, Male and Female
Study Type
NCD ID
Protocol IDs
NCT02563002 (primary)
Study Sponsor
Merck Sharp & Dohme
NCI Full Details
Georgia CORE

 

Hearts and Minds Dedicated to Improving Cancer Care

Georgia CORE is a public-private partnership that creates collaboration among the state’s cancer organizations and institutions to connect more Georgians to quality, personalized cancer care. We welcome you to this one-of-a-kind online information center for all things related to cancer and survivorship care in Georgia.